(Q50438014)

14 March 2018

title

A chemical chaperone-based drug candidate is effective in a mouse model of amyotrophic lateral sclerosis (ALS). (English)

1 reference

14 March 2018

amyotrophic lateral sclerosis

main subject

0 references

0 references

8

1 reference

14 March 2018

Adrian Israelson

13

1 reference

14 March 2018

Inchan Kwon

object named as

Inchan Kwon

14

0 references

Susanne Petri

15

object named as

Susanne Petri

1 reference

14 March 2018

Tamar Getter

1

1 reference

14 March 2018

Ilana Zaks

2

1 reference

14 March 2018

Yael Barhum

3

1 reference

14 March 2018

Tali Ben-Zur

4

1 reference

14 March 2018

Sebastian Böselt

5

1 reference

14 March 2018

Simpson Gregoire

6

1 reference

14 March 2018

Olga Viskind

7

1 reference

14 March 2018

Hugo Gottlieb

9

1 reference

14 March 2018

Omer Green

10

1 reference

14 March 2018

Moran Shubely

11

1 reference

14 March 2018

Hanoch Senderowitz

12

1 reference

14 March 2018

Daniel Offen

16

1 reference

14 March 2018

Arie Gruzman

17

1 reference

14 March 2018

publication date

13 March 2015

1 reference

14 March 2018

published in

ChemMedChem

1 reference

14 March 2018

volume

10

1 reference

14 March 2018

issue

5

1 reference

14 March 2018

page(s)

850-861

1 reference

14 March 2018

Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

SOD1 aggregation and ALS: role of metallation states and disulfide status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Mechanism and treatment of motoneuron degeneration in ALS: what have SOD1 mutants told us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Amyotrophic lateral sclerosis: an update on recent genetic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Mutant SOD1 instability: implications for toxicity in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Pathogenic superoxide dismutase structure, folding, aggregation and turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Current hypotheses for the underlying biology of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Chemical and Pharmacological Chaperones: Application for Recombinant Protein Production and Protein Folding Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Entropic stabilization of proteins by TMAO

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

The Unexpected Uses of Urso- and Tauroursodeoxycholic Acid in the Treatment of Non-liver Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Defining the mechanism of action of 4-phenylbutyrate to develop a small-molecule-based therapy for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Structure-brain exposure relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Demystifying brain penetration in central nervous system drug discovery. Miniperspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Blood-brain barrier penetration of novel pyridinealdoxime methiodide (PAM)-type oximes examined by brain microdialysis with LC-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Chemical delivery systems for some penicillinase-resistant semisynthetic penicillins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Metabolism of pyridalyl in rats: excretion, distribution, and biotransformation of dichloropropenyl-labeled pyridalyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Mutant superoxide dismutase 1 overexpression in NSC-34 cells: effect of trehalose on aggregation, TDP-43 localization and levels of co-expressed glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Riluzole increases the rate of glucose transport in L6 myotubes and NSC-34 motor neuron-like cells via AMPK pathway activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Astrocytes from familial and sporadic ALS patients are toxic to motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

ER stress-induced cell death mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Cis-suppression to arrest protein aggregation in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Proteasome activation is a mechanism for pyrazolone small molecules displaying therapeutic potential in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Strategic approaches to developing drug treatments for ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Binding and transport of [3H](2S,4R)- 4-methylglutamate, a new ligand for glutamate transporters, demonstrate labeling of EAAT1 in cultured murine astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Benzothiazole derivatives augment glucose uptake in skeletal muscle cells and stimulate insulin secretion from pancreatic β-cells via AMPK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Rearrangements of N-Oxides. A Novel Synthesis of Pyridyl Carbinols and Aldehydes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Preclinical research: Make mouse studies work

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

Kinetic isotope effects implicate a single oxidant for cytochrome P450-mediated O-dealkylation, N-oxygenation, and aromatic hydroxylation of 6-methoxyquinoline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

inferred from DOI database lookup

7 January 2021

based on heuristic

Synthesis of 2-aryl-6-methyl-5-nitroquinoline derivatives as potential prodrug systems for reductive activation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201500045

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CMDC.201500045

1 reference

14 March 2018

1 reference

14 March 2018